Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 4/1/24 → 4/1/26 |
Funding
- Sanofi Aventis US Inc: $20,300.00
23-HEM-20-SA (EFC17757): A Randomized, Double-blind, Multicenter,Phase 3 Study to Evaluate Efficacy and Safety of Belumosudil in Combination With Corticosteroids Versus Placebo in Combination with Corticosteroids in Participants at Least 12 Years of Age W
- Qasrawi, Ayman (PI)
- Ramlal, Reshma (Former PI)